Antimicrobial Resistance of Clinical Isolates of Acinetobacter spp. Collected from Non-Tertiary Hospitals and Detection of a Metallo-beta-Lactamase-Producing Strain.
- Author:
Jeom Kyu LEE
1
;
Yong Sun YOO
;
Yeong Seon LEE
;
Jae Il YOO
;
Bong Su KIM
Author Information
1. Division of Antimicrobial Resistant Pathogens, Department of Bacteriology, National Institute of Health, Korea Center for Disease Control and Prevention, Seoul, Korea. bongsukim@hanmail.net
- Publication Type:Original Article
- Keywords:
Acinetobacter spp.;
Antimicrobial resistance;
Integron;
blaVIM-2
- MeSH:
Acinetobacter*;
Agar;
Aminoglycosides;
Anti-Infective Agents;
beta-Lactams;
Diffusion;
Fluoroquinolones;
Genotype;
Imipenem;
Integrons;
Phenotype;
Polymerase Chain Reaction;
Sequence Analysis
- From:
Infection and Chemotherapy
2004;36(5):271-278
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: The aim of this study was to investigate the antimicrobial resistance of clinical isolates of Acinetobacter spp. collected from non-tertiary hospitals and to characterize the phenotype and the genotype of imipenem-non-susceptible isolates. MATERIALS AND METHODS: Clinical isolates of Acinetobacter spp. were identified using recA-restriction fragment length polymorphism (RFLP) analysis with Tsp5091. Susceptibility to antimicrobial agents was determined using disk diffusion test and agar dilution test according to the criteria of the National Committee for Clinical Laboratory Standards. PCR and sequence analyses were used to detect the blaIMP-1 and blaVIM-2 genes, and to determine the content and order of the resistance genes inserted in integron. RESULTS: Of 71 Acinetobacter spp. isolates collected from non-tertiary hospitals during 2002 and 2003, 60 isolates were A. baumannii, and 2, 4, and 5 isolates were Acinetobacter genomic species 3, 13TU, and A. lwoffii, respectively. The resistance rate of Acinetobacter spp. isolates to beta-lactams, aminoglycosides, and fluoroquinolones was high except for imipenem and meropenem. The presence of blaVIM-2 gene was found in one isolate, Acinetobacter genomic species 13TU, for which the MIC of imipenem was 8 mg/L; the blaVIM-2 gene of this strain was located on 3 kb class 1 integron with aacA7 and aadA1 genes. CONCLUSIONS: Among the tested agents, imipenem and meropenem retained greatest activity against Acinetobacter spp. isolates collected from non-tertiary hospitals. This is the first report of VIM-2-producing Acinetobacter genomic species 13TU strains with class 1 integron containing blaVIM-2 gene.
